The PREEMIE Reauthorization Act of 2023 extends federal funding for research and care related to preterm births and low birthweight infants through fiscal years 2024-2028, replacing previous funding periods. It updates existing programs to include screening for and treatment of chronic conditions in infant care and requires the Health and Human Services Secretary to establish an interagency working group within 18 months. The bill mandates a National Academies study to assess financial costs of preterm birth (including neonatal ICU stays and long-term family expenses), factors influencing birth rates, gaps in public health support, and research strategies for prevention, with a final report due within 24 months. This legislation directly affects federal health agencies, healthcare providers, and families caring for preterm infants by advancing evidence-based improvements in care.
This bill modifies the U.S. International Development Finance Corporation's (DFC) authority to enhance its role in global development and U.S. strategic interests. It expands the DFC's ability to provide equity financing (not just loans or insurance) for projects, adjusts budgetary treatment to avoid federal credit reform rules, and increases the maximum contingent liability cap from $60 billion to $100 billion. The changes directly affect DFC-funded projects, particularly those involving private sector investments in developing countries, including fragile or conflict-affected states. It also requires the DFC to submit a 180-day plan detailing how it will expand financing for U.S. national security and development priorities.
This bill requires federal agencies to adjust contract prices for contractors who suspended work due to government shutdowns (lapses in appropriations). It mandates that contractors receive reimbursement for reasonable costs incurred to pay furloughed or laid-off employees their standard wages during the shutdown, or to restore paid leave used during the shutdown. The reimbursement is capped at $1,442 per week (pro-rated for part-time work) and must be documented by contractors. It directly affects federal contractors and their employees who experienced pay disruptions during the 2023-2024 government shutdowns.
The SHOP SAFE Act of 2023 holds online marketplaces (like Amazon or eBay) financially responsible if third-party sellers on their platforms sell counterfeit products that pose health or safety risks, such as unsafe consumer goods. To avoid liability, platforms must implement specific, free measures: verify seller identities, proactively screen listings for counterfeits, quickly remove suspicious items, and terminate sellers who repeatedly sell fake products. The law applies to platforms with $500,000+ in annual sales or smaller platforms after receiving 10 verified counterfeit notices. It defines "health-safety-implicating goods" as products that could cause harm if not made to safety standards (e.g., faulty electronics or unsafe toys). The bill aims to shift accountability to platforms for counterfeit sales that endanger consumers, without restricting other trademark protections.
This joint resolution commemorates the fifth anniversary of the murder of Saudi journalist Jamal Khashoggi, who was killed in 2018 at the Saudi consulate in Istanbul. It calls on the Saudi government to ensure accountability for those responsible for his death, release individuals wrongfully detained (including activists and dissidents), lift travel bans on critics, and respect freedoms of assembly and expression. The resolution notes that the U.S. has already sanctioned 17 Saudi officials under the Global Magnitsky Act for their role in the murder. As a non-binding resolution, it urges the executive branch to pursue these actions without creating new legal obligations.
SRES 388 is a ceremonial Senate resolution designating the week of September 25-29, 2023, as "National Clean Energy Week." It does not create new laws or programs but formally recognizes the importance of clean energy through symbolic designation. The resolution encourages individuals, organizations, and governments to support clean energy solutions and invest in affordable, low-emission technologies. It highlights the clean energy sector’s role in job creation (citing 8.1 million U.S. jobs in 2022) and economic growth without imposing any new requirements.
This resolution designates the week of September 25-29, 2023, as "National Clean Energy Week" to recognize the growing role of clean energy in the U.S. economy. It expresses support for clean energy jobs and innovation, noting the sector employed about 8.1 million people in 2022. The resolution encourages federal, state, and local investment in affordable clean energy technologies and promotes "commonsense solutions" for energy needs. As a symbolic gesture, it has no legal force or funding implications - it simply urges recognition of clean energy's economic and environmental contributions.
The NEWBORN Act creates a federal grant program to reduce infant mortality in the 50 U.S. counties with the highest rates, using $10 million annually from 2023-2027. It funds local health departments (including tribal, county, or state agencies) to design pilot programs addressing causes like preterm birth, maternal complications, and infant injuries through community assessments, outreach to at-risk mothers, and coordinated services such as postpartum care and smoking cessation. Grantees must report annually on program outcomes and methods, with no more than 10% of funds used for evaluation. The bill directly affects communities in high-mortality areas by supporting targeted, evidence-based interventions.
This bill authorizes $70 million annually (2024-2028) to strengthen CDC asthma programs, requiring states to collect detailed data on asthma rates, hospital visits, and emergency department use by race, age, and location. It mandates CDC collaboration with states to develop targeted asthma control plans, improve public education about triggers and management, and publish annual reports tracking progress on reducing health disparities. The bill directly affects all Americans with asthma - particularly communities disproportionately impacted by higher rates (such as Black Americans, Native individuals, Puerto Ricans, and low-income populations) - by improving data-driven public health responses. Key mechanisms include standardized data collection from health records, annual public reporting, and congressional reports evaluating federal and state efforts to reduce asthma-related hospitalizations and mortality.
This bill directs the CDC to launch public education campaigns about blood clot risks, symptoms, and prevention, with special focus on high-risk groups including Black Americans, cancer patients, seniors, and hospitalized individuals. It creates a new 18-month advisory committee to study DVT/PE data collection, develop prevention guidelines, and recommend improved care standards for at-risk patients. The bill also mandates a federal study on electronic health record systems for better DVT/PE surveillance and authorizes $20 million annually for these efforts through fiscal year 2029. These provisions aim to reduce preventable deaths and improve early diagnosis, directly affecting millions at risk of blood clots nationwide.
This resolution designates September 25-29, 2023, as "National Hazing Awareness Week" to highlight hazing prevention efforts. It does not create new laws or policies but formally recognizes the issue and encourages public awareness. The Senate emphasizes that hazing prevention requires ongoing commitment beyond a single week, urging communities to promote safety and well-being. It directly affects the general public, educational institutions, and campus communities by raising visibility for a longstanding concern.
This bill (S 2982) mandates a study by the Government Accountability Office (GAO) into online sales of fentanyl and methamphetamine. The GAO must examine business models used by illicit sellers, how financial transactions occur via online platforms (especially impacting users under 18), federal and state government collaboration efforts, and how platforms detect and report drug sales. The study will analyze enforcement processes, referral patterns to law enforcement, and identify gaps in current efforts. The GAO must submit a report to Congress within one year of the bill's enactment. This is a procedural study bill with no immediate policy changes or direct impact on citizens or businesses.
